Logo image of ALFEN.AS

ALFEN N.V. (ALFEN.AS) Stock Fundamental Analysis

Europe - Euronext Amsterdam - AMS:ALFEN - NL0012817175 - Common Stock

10.305 EUR
+0.04 (+0.39%)
Last: 12/9/2025, 5:29:56 PM
Fundamental Rating

4

Taking everything into account, ALFEN scores 4 out of 10 in our fundamental rating. ALFEN was compared to 66 industry peers in the Electrical Equipment industry. While ALFEN seems to be doing ok healthwise, there are quite some concerns on its profitability. ALFEN is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year ALFEN has reported negative net income.
ALFEN had a positive operating cash flow in the past year.
ALFEN had positive earnings in 4 of the past 5 years.
Each year in the past 5 years ALFEN had a positive operating cash flow.
ALFEN.AS Yearly Net Income VS EBIT VS OCF VS FCFALFEN.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M

1.2 Ratios

With a Return On Assets value of -5.09%, ALFEN is not doing good in the industry: 65.15% of the companies in the same industry are doing better.
ALFEN has a Return On Equity of -11.40%. This is in the lower half of the industry: ALFEN underperforms 65.15% of its industry peers.
Industry RankSector Rank
ROA -5.09%
ROE -11.4%
ROIC N/A
ROA(3y)5.52%
ROA(5y)7.16%
ROE(3y)11.34%
ROE(5y)14.49%
ROIC(3y)N/A
ROIC(5y)N/A
ALFEN.AS Yearly ROA, ROE, ROICALFEN.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40

1.3 Margins

ALFEN has a Gross Margin (34.60%) which is in line with its industry peers.
In the last couple of years the Gross Margin of ALFEN has declined.
ALFEN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 34.6%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.42%
GM growth 5Y-4.61%
ALFEN.AS Yearly Profit, Operating, Gross MarginsALFEN.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

6

2. Health

2.1 Basic Checks

ALFEN does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ALFEN has about the same amount of shares outstanding.
The number of shares outstanding for ALFEN has been increased compared to 5 years ago.
Compared to 1 year ago, ALFEN has an improved debt to assets ratio.
ALFEN.AS Yearly Shares OutstandingALFEN.AS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
ALFEN.AS Yearly Total Debt VS Total AssetsALFEN.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

ALFEN has an Altman-Z score of 2.64. This is not the best score and indicates that ALFEN is in the grey zone with still only limited risk for bankruptcy at the moment.
ALFEN has a Altman-Z score of 2.64. This is in the better half of the industry: ALFEN outperforms 66.67% of its industry peers.
ALFEN has a debt to FCF ratio of 0.99. This is a very positive value and a sign of high solvency as it would only need 0.99 years to pay back of all of its debts.
The Debt to FCF ratio of ALFEN (0.99) is better than 90.91% of its industry peers.
ALFEN has a Debt/Equity ratio of 0.26. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of ALFEN (0.26) is better than 68.18% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF 0.99
Altman-Z 2.64
ROIC/WACCN/A
WACC7.91%
ALFEN.AS Yearly LT Debt VS Equity VS FCFALFEN.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

ALFEN has a Current Ratio of 1.75. This is a normal value and indicates that ALFEN is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.75, ALFEN is in the better half of the industry, outperforming 63.64% of the companies in the same industry.
ALFEN has a Quick Ratio of 1.09. This is a normal value and indicates that ALFEN is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.09, ALFEN is in the better half of the industry, outperforming 63.64% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.75
Quick Ratio 1.09
ALFEN.AS Yearly Current Assets VS Current LiabilitesALFEN.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

4

3. Growth

3.1 Past

ALFEN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -287.72%.
Looking at the last year, ALFEN shows a very negative growth in Revenue. The Revenue has decreased by -13.84% in the last year.
The Revenue has been growing by 27.79% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-287.72%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%88.16%
Revenue 1Y (TTM)-13.84%
Revenue growth 3Y25%
Revenue growth 5Y27.79%
Sales Q2Q%-13.92%

3.2 Future

The Earnings Per Share is expected to grow by 48.45% on average over the next years. This is a very strong growth
ALFEN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.16% yearly.
EPS Next Y184.95%
EPS Next 2Y85.66%
EPS Next 3Y60.79%
EPS Next 5Y48.45%
Revenue Next Year-9.49%
Revenue Next 2Y-2.72%
Revenue Next 3Y0.44%
Revenue Next 5Y3.16%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ALFEN.AS Yearly Revenue VS EstimatesALFEN.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M
ALFEN.AS Yearly EPS VS EstimatesALFEN.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.5 1 1.5 2

4

4. Valuation

4.1 Price/Earnings Ratio

ALFEN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
With a Price/Forward Earnings ratio of 44.61, ALFEN can be considered very expensive at the moment.
Based on the Price/Forward Earnings ratio, ALFEN is valued a bit more expensive than 60.61% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.56, ALFEN is valued quite expensively.
Industry RankSector Rank
PE N/A
Fwd PE 44.61
ALFEN.AS Price Earnings VS Forward Price EarningsALFEN.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30 40

4.2 Price Multiples

ALFEN's Enterprise Value to EBITDA is on the same level as the industry average.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of ALFEN indicates a rather cheap valuation: ALFEN is cheaper than 95.45% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 4.51
EV/EBITDA 27.83
ALFEN.AS Per share dataALFEN.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

ALFEN's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ALFEN's earnings are expected to grow with 60.79% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y85.66%
EPS Next 3Y60.79%

0

5. Dividend

5.1 Amount

No dividends for ALFEN!.
Industry RankSector Rank
Dividend Yield N/A

ALFEN N.V.

AMS:ALFEN (12/9/2025, 5:29:56 PM)

10.305

+0.04 (+0.39%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)11-04 2025-11-04
Earnings (Next)02-10 2026-02-10/amc
Inst Owners42.69%
Inst Owner ChangeN/A
Ins Owners0.56%
Ins Owner ChangeN/A
Market Cap224.13M
Revenue(TTM)453.43M
Net Income(TTM)-17.25M
Analysts44.71
Price Target10.11 (-1.89%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1%
PT rev (3m)-4.89%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)1216.7%
EPS NY rev (3m)318.93%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-2.99%
Revenue NY rev (3m)-5.92%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 44.61
P/S 0.49
P/FCF 4.51
P/OCF 3.45
P/B 1.48
P/tB 1.84
EV/EBITDA 27.83
EPS(TTM)-0.79
EYN/A
EPS(NY)0.23
Fwd EY2.24%
FCF(TTM)2.28
FCFY22.16%
OCF(TTM)2.99
OCFY29%
SpS20.85
BVpS6.96
TBVpS5.59
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -5.09%
ROE -11.4%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 34.6%
FCFM 10.95%
ROA(3y)5.52%
ROA(5y)7.16%
ROE(3y)11.34%
ROE(5y)14.49%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.42%
GM growth 5Y-4.61%
F-Score5
Asset Turnover1.34
Health
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF 0.99
Debt/EBITDA 4.36
Cap/Depr 56.5%
Cap/Sales 3.38%
Interest Coverage N/A
Cash Conversion 709.26%
Profit Quality N/A
Current Ratio 1.75
Quick Ratio 1.09
Altman-Z 2.64
F-Score5
WACC7.91%
ROIC/WACCN/A
Cap/Depr(3y)181.87%
Cap/Depr(5y)166.2%
Cap/Sales(3y)5.57%
Cap/Sales(5y)5.29%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-287.72%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%88.16%
EPS Next Y184.95%
EPS Next 2Y85.66%
EPS Next 3Y60.79%
EPS Next 5Y48.45%
Revenue 1Y (TTM)-13.84%
Revenue growth 3Y25%
Revenue growth 5Y27.79%
Sales Q2Q%-13.92%
Revenue Next Year-9.49%
Revenue Next 2Y-2.72%
Revenue Next 3Y0.44%
Revenue Next 5Y3.16%
EBIT growth 1Y-211.55%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year718.66%
EBIT Next 3Y116.96%
EBIT Next 5Y70.87%
FCF growth 1Y164.76%
FCF growth 3YN/A
FCF growth 5Y33.38%
OCF growth 1Y242.64%
OCF growth 3Y74.32%
OCF growth 5Y31.69%

ALFEN N.V. / ALFEN.AS FAQ

What is the ChartMill fundamental rating of ALFEN N.V. (ALFEN.AS) stock?

ChartMill assigns a fundamental rating of 4 / 10 to ALFEN.AS.


What is the valuation status of ALFEN N.V. (ALFEN.AS) stock?

ChartMill assigns a valuation rating of 4 / 10 to ALFEN N.V. (ALFEN.AS). This can be considered as Fairly Valued.


Can you provide the profitability details for ALFEN N.V.?

ALFEN N.V. (ALFEN.AS) has a profitability rating of 2 / 10.


What is the financial health of ALFEN N.V. (ALFEN.AS) stock?

The financial health rating of ALFEN N.V. (ALFEN.AS) is 6 / 10.


What is the expected EPS growth for ALFEN N.V. (ALFEN.AS) stock?

The Earnings per Share (EPS) of ALFEN N.V. (ALFEN.AS) is expected to grow by 184.95% in the next year.